TTrialPathMatch Me to Trials
← Back to trials
RecruitingLung Cancer (Diagnosis)Liver Cancer, AdultPancreatic Cancer

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Eligible age

21+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.

Sponsor: Varian, a Siemens Healthineers Company

You may qualify if…

  • ✓ 1. Target lesions in the thorax or upper abdomen
  • ✓ 2. Planned to undergo SBRT radiation treatment delivered on a conventional "C-arm" or ring gantry CBCT guided linear accelerator under breath hold conditions
  • ✓ 3. ECOG performance status 0-1
  • ✓ 4. At least 21 years of age
  • ✓ 5. Able to sign informed consent

You may not qualify if…

  • ✕ 1. Participants enrolled in another clinical investigation the investigator believes to be in conflict with this clinical investigation.
  • ✕ 2. Participants with any other medical condition or laboratory value that would, at the discretion of the investigator, preclude the patient from participation in this clinical investigation.

Where it's recruiting

Missouri

St Louis

Ohio

Cleveland

Source: ClinicalTrials.gov · NCT07824583 · last updated 2026-09-17

A Study Evaluating a New Radiation Treatment Workflow (NGDS) · TrialPath